位置:首页 > 蛋白库 > PA2H_CROAT
PA2H_CROAT
ID   PA2H_CROAT              Reviewed;         137 AA.
AC   Q8UVZ7;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   25-MAY-2022, entry version 84.
DE   RecName: Full=Basic phospholipase A2 homolog Cax-K49 {ECO:0000303|PubMed:11594738};
DE            Short=svPLA2 homolog;
DE   Flags: Precursor;
OS   Crotalus atrox (Western diamondback rattlesnake).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Crotalus.
OX   NCBI_TaxID=8730;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 17-45, FUNCTION, MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=11594738; DOI=10.1006/abbi.2001.2524;
RA   Tsai I.-H., Chen Y.-H., Wang Y.-M., Tu M.-C., Tu A.T.;
RT   "Purification, sequencing, and phylogenetic analyses of novel Lys-49
RT   phospholipases A(2) from the venoms of rattlesnakes and other pit vipers.";
RL   Arch. Biochem. Biophys. 394:236-244(2001).
RN   [2]
RP   PROTEIN SEQUENCE OF 17-49; 54-64; 77-85 AND 88-99, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=19371136; DOI=10.1021/pr900249q;
RA   Calvete J.J., Fasoli E., Sanz L., Boschetti E., Righetti P.G.;
RT   "Exploring the venom proteome of the western diamondback rattlesnake,
RT   Crotalus atrox, via snake venomics and combinatorial peptide ligand library
RT   approaches.";
RL   J. Proteome Res. 8:3055-3067(2009).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic
CC       activity (PubMed:11594738). Displays edema-inducing activities and may
CC       be myotoxic (PubMed:11594738). A model of myotoxic mechanism has been
CC       proposed: an apo Lys49-PLA2 is activated by the entrance of a
CC       hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of
CC       the protein leading to a reorientation of a monomer (By similarity).
CC       This reorientation causes a transition between 'inactive' to 'active'
CC       states, causing alignment of C-terminal and membrane-docking sites
CC       (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in
CC       the same plane, exposed to solvent and in a symmetric position for both
CC       monomers (By similarity). The MDoS region stabilizes the toxin on
CC       membrane by the interaction of charged residues with phospholipid head
CC       groups (By similarity). Subsequently, the MDiS region destabilizes the
CC       membrane with penetration of hydrophobic residues (By similarity). This
CC       insertion causes a disorganization of the membrane, allowing an
CC       uncontrolled influx of ions (i.e. calcium and sodium), and eventually
CC       triggering irreversible intracellular alterations and cell death (By
CC       similarity). {ECO:0000250|UniProtKB:I6L8L6,
CC       ECO:0000269|PubMed:11594738}.
CC   -!- SUBUNIT: Homodimer; non-covalently linked.
CC       {ECO:0000250|UniProtKB:I6L8L6}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11594738,
CC       ECO:0000269|PubMed:19371136}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:11594738, ECO:0000305|PubMed:19371136}.
CC   -!- MASS SPECTROMETRY: Mass=13779; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11594738};
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II subfamily.
CC       K49 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding sites is
CC       lost (Asp->Lys in position 64, which corresponds to 'Lys-49' in the
CC       current nomenclature). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF269130; AAL36973.1; -; mRNA.
DR   AlphaFoldDB; Q8UVZ7; -.
DR   SMR; Q8UVZ7; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Myotoxin; Secreted; Signal;
KW   Toxin.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:11594738,
FT                   ECO:0000269|PubMed:19371136"
FT   CHAIN           17..137
FT                   /note="Basic phospholipase A2 homolog Cax-K49"
FT                   /id="PRO_0000022852"
FT   REGION          121..133
FT                   /note="Important for membrane-damaging activities in
FT                   eukaryotes and bacteria; heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   SITE            121
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            124
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            128
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            130
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            133
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   DISULFID        42..131
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        44..60
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        59..111
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        65..137
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        66..104
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        73..97
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        91..102
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
SQ   SEQUENCE   137 AA;  15597 MW;  63E5F80D0565AEE6 CRC64;
     MRTFWIVAML LVGVEGSLVE LGKMILQETG KNPITSYGIY GCNCGVGSRH KPKDGTDRCC
     FVHKCCYKKL TDCDPKMDGY TYSFKDKTII CDVNNPCLKE MCECDKAVAI CLRENLDTYN
     KKYKIYPKFL CKKPDTC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024